Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-19-052312
Date:2019-09-27
Issuer: ABBVIE INC. (ABBV)
Original Submission Date:

Reporting Person:

RICHMOND TIMOTHY J.
1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL 60064

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.01 PAR VALUE 2019-09-27 S 15,515 d $75.02 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $75.00 to $75.02, inclusive. the reporting person undertakes to provide abbvie inc., any security holder of abbvie inc. or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
WhaleWisdom Logo

Elevate your investments